openPR Logo
Press release

Non-Sterile Compounding Pharmacy Market Mega Trends 2018 | By Product - Oral Medication, Topical Medication, Otologic/Nasal Medication and Foreseeing to 2023

04-09-2018 11:24 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Non-Sterile Compounding Pharmacy Market

Non-Sterile Compounding Pharmacy Market

Non-Sterile Compounding Pharmacy Market is growing continuously and is expected to grow at a CAGR of 2.65% from 2017 to 2023. Compounding involves the customization of the medicine based on the physician prescription. The pharmacist customizes the dosage or strength and reformulates the drug by excluding unwanted ingredients to which the patient is allergic, or may change the form of the medicine for the patients who are unable to swallow the oral medications.

Non-Sterile Compounding Pharmacy Market: Key players  

Fagron (the Netherlands), B.Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), TRUE NATURE HOLDING, INC (U.S), Dougherty's Pharmacy Inc. (U.S.), and PHARMEDIUM (U.S.).

Ask for Sample Page @ https://www.marketresearchfuture.com/sample_request/4669 .

Segments:  

The U.S. & Europe non-sterile compounding pharmacy market is segmented into product, application, and end user. By type, the market is segmented into oral medication, topical medication, otologic/nasal medication, and others. The oral medications are further segmented into solid and liquid preparations. The topical medications include ointments, creams, gels, pastes, and others. By application, the market is segmented into pain medication, hormone replacement therapy, and others. By end user, the market is segmented into hospitals, compounding pharmacy, and others.

Non-Sterile Compounding Pharmacy Market: Regional Analysis

America is holding the first position in the market for non-sterile compounding pharmacy owing to the rising demand for customized medicine, increasing prevalence of chronic diseases such as diabetes, and rising number of hospital-based compounding pharmacies. As per the Center for Diseases Control and Prevention (CDC) in 2015, 30.3 million Americans, i.e. 9.4% of the population had diabetes. Additionally, 1.25 million American children and adults had type 1 diabetes.

Europe is the second largest non-sterile compounding pharmacy market across the globe. In Europe, growing awareness about compounding pharmaceutical products for the treatment of chronic diseases such as diabetes, drug allergies, and increasing number of prescriptions for the compounded medications propel the growth of the market. According to the European Academy of Allergy and Clinical Immunology (EAACI), around 2.6% hospitalization happens due to adverse drug effects, while the prevalence of drug allergy in the hospitalized patients is about 10% in the Europe.

Non-Sterile Compounding Pharmacy Market: Market Synopsis

The U.S. Pharmacopeia Convention (USP) formally defines compounding as ‘the preparation, mixing, assembling, altering, packaging, and labelling of a drug, drug-delivery device in accordance with a licensed practitioner's prescription, medication order, or initiative based on the practitioner/patient/ pharmacist/compounder relationship in the course of professional practice.’ Products manufactured by a compounding pharmacy are customized according to the patient need.

Get Discount Page @ https://www.marketresearchfuture.com/check-discount/4669 .

The market for non-sterile compounding pharmacy is driven by an increasing prevalence of chronic diseases such as diabetes, rising need for customized medicine and increasing geriatric population. Furthermore, the demand for anti-aging products that use custom compounded drugs is growing in the U.S. and Europe. However, the strict regulations governing the manufacturing of the compounded product and high prices restrain the market growth. The U.S. & Europe non-sterile compounding pharmacy market is expected to grow steadily at a CAGR of 2.65% during the forecast period.

List of Tables:

Table 1 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Product,
2014- 2023 (Usd Million) 39
Table 2 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Oral Medications,
By Region, 2014-2023 (Usd Million) 41
Table 3 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Topical Medications,
By Region, 2014-2023 (Usd Million) 42
Table 4 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Otologic/
Nasal Medication, By Region, 2014-2023 (Usd Million) 43
Table 5 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Application,
2014-2023 (Usd Million) 45
Table 6 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By End User,
2014-2023 (Usd Million) 48
Table 7 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By Region,
2014-2023 (Usd Million) 49
Table 8 U.S. Non- Sterile Compounding Pharmacy Market, By Region, 2014-2023 (Usd Million) 51
Table 9 U.S. Liquid Preparation Market, By Volume, 2014-2023 (Units) 51
Table 10 U.S. Syrups Market, By Volume, 2014-2023 (Units) 51

And more…

List of Figures:

FIGURE 1 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT MARKET SHARE,
FIGURE 2 U.S. & EUROPE NON- STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION, MARKET SHARE
FIGURE 3 U.S. AND EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET BY END USER, MARKET SHARE
FIGURE 4 MARKET STRUCTURE
FIGURE 5 RESEARCH PROCESS
FIGURE 6 FORECAST MODEL
FIGURE 7 VALUE CHAIN:NON-STERILE COMPOUNDING PHARMACY MARKET
FIGURE 8 PORTERS FIVE FORCES MODEL
FIGURE 9 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT,
2016 & 2023 (USD MILLION)
FIGURE 10 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION,
2014- 2023 (USD MILLION)
FIGURE 11 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET: COMPANY SHARE ANALYSIS
FOR THE KEY PLAYERS, 2016 (%)

Have Any Query, Ask to our Expert @ https://www.marketresearchfuture.com/enquiry/4669 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Sterile Compounding Pharmacy Market Mega Trends 2018 | By Product - Oral Medication, Topical Medication, Otologic/Nasal Medication and Foreseeing to 2023 here

News-ID: 1007452 • Views: 643

More Releases from Market Research Future

CAS9 technology Market Projected to Hit USD 6.72 Billion at a 11.30% CAGR by 203 …
Market overview: The overall CAS9 technology industry is expected to grow over the future years because of its significant economic nature and expanding use opportunities. During 2018- 2030, the industry is anticipated to develop at a compound yearly rate of economic development of 11.30 %. Genetic engineering has advanced with the advent of genomics and genetic manipulation using designed nucleases. As a method for genomics, the CAS9 technique is swiftly gaining
Cloud Billing Market Projected to Hit USD 13.23 Billion at a 16.40% CAGR by 2030 …
Market Overview: The value of the Cloud Billing Market is anticipated to be USD 13.23 billion by the year 2030, growing at a CAGR of 16.40% during the period of forecasting from 2020 to 2030. Cloud billing creates invoices using valuable informational data following previously established billing standards. A cloud-based billing feature serves as a conduit for generating consumption invoices. There will be growth in the cloud billing market in the next
Thermal Paper Market Size 2021: Industry Analysis, Share, Segmentation, Price Tr …
Overview The thermal paper market is anticipated to grow rapidly at a CAGR of 4.87% during the forecast period. The global thermal paper market is driven by increased demand for thermal paper for POS application. These factors have helped shape the thermal paper market and are expected to boost the growth. Companies in the thermal paper market could also face challenges such as increasing demand for paperless billing and volatility in
Dry Bulk Shipping Market 2022 , Share, Size, Growth, Top Manufacturers, Segmenta …
Market Overview Market research indicates that the global market of Dry Bulk Shipping Market Revenue is going to reach up to USD 5,400 Million (approx) within the forecast period 2022-2030 with a CAGR of 4%. Get sample copy of report at: https://www.marketresearchfuture.com/sample_request/8308 Dry Bulk Shipping is the transportation of bulk commodities such as grains, iron ore, coal, lumber, sand, gravel, steel products like rods, plates, coils, and others using vessels. According to

All 5 Releases


More Releases for Compounding

NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
Compounding Pharmacies Market 2020: Top Key Players Are Triangle Compounding Pha …
Industry Overview: Updated research report on Compounding Pharmacies Market by ‘Market Growth Insight’ delivers pivotal information on the market including drivers, restraints, challenges, and opportunities. The Compounding Pharmacies report is useful to business owners, manufacturers, distributors, suppliers, marketing personnel, strategists, and customers since it helps them to understand the current market scenario and make future planning, while considering the risks that are also mentioned in the report. The Compounding Pharmacies report
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc. Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured